Key facts
- Notable investors include Caffeinated Capital, Scribble Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Crownlands
- ·The full record, as it builds
Funding rounds
No funding rounds for Crownlands are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Crownlands
Developer of a drug development platform designed to facilitate drug discovery for neurodegenerative diseases. The company's platform leverages noninvasive technology to sequence human neurons at scale, enabling pharmaceutical and biotechnology researchers to sequence human neurons one synapse away from the brain, collected noninvasively at unmatched scale.
- Sector
- Healthcare
- HQ
- CA
- Website
- crownlands.com/
- Ownership
- Privately Held (backing)
Crownlands doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Crownlands shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Crownlands in its N-PORT filings yet. We sweep new filings monthly.